DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Pollack Jr CV, Reilly PA, Eikelboom J. , et al.
Idarucizumab for dabigatran reversal.
N Engl J Med 2015;
373 (06) 511-520
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.